Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(3):156-157; doi:10.1093/jnci/djj058
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Rice, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rice, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

Very Early Detection? British Group Gauges Public Interest in Embryo Testing for Cancer

Mary Rice

The first 10% of the full text of this article appears below.

Last fall, the Human Fertilization and Embryology Authority (HFEA), which regulates British fertility treatment and embryo research, posed a tough question to the public: Should embryo testing for cancer susceptibility genes be made widely available in the United Kingdom?

Preimplantation genetic diagnosis (PGD) can be used in in vitro fertilization to test embryos for conditions such as cystic fibrosis, Huntington disease, and hemophilia. But unlike these diseases, cancer susceptibility conditions have a lower penetrance (that is, not everyone with the faulty gene will develop the cancer); the occurrence of disease may have a later age of onset; and there is the possibility of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
A.L. Bredenoord, G. Pennings, H.J. Smeets, and G. de Wert
Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders
Hum. Reprod. Update, January 1, 2008; 14(1): 83 - 94.
[Abstract] [Full Text] [PDF]